Use Oraqix (lidocaine and prilocaine periodontal gel) 2.5%/2.5% to fight fear

Article

Like all dentists, Veasey B. Cullen, Jr., DMD, is well aware that most patients are afraid of injections. That’s why this longtime periodontist with practices in York and Hanover, Pa., loves using Oraqix topical anesthetic gel from DENTSPLY Pharmaceutical.

Like all dentists, Veasey B. Cullen, Jr., DMD, is well aware that most patients are afraid of injections. That’s why this longtime periodontist with practices in York and Hanover, Pa., loves using Oraqix topical anesthetic gel from DENTSPLY Pharmaceutical.

The product, which can be delivered quickly by his hygienists, allows him to work more efficiently, but, more importantly, it helps patients avoid the fright of injections in many cases.

What the dentist, Dr. Veasey B. Cullen, Jr., thinks about Oraqix
To me, the whole thing with dentistry has changed. Everybody’s afraid of pain. That’s why there are big access-to-care issues. People don’t want to access care because they’re afraid of what happens.

They talk about decayed teeth costing hours of work … it all comes down to fear. And fear is related to pain. And, obviously, the best way to avoid pain is with a topical.

Nobody comes in and says, “I want my injection.” Of course, Oraqix is a great topical product. I’d say its only drawback is taste. Some people don’t like it, but, boy, they sure accept it as opposed to being uncomfortable.

Related reading: New denture teeth options from DENTSPLY Prosthetics

As a periodontist, my treatment is site-specific. We have disease at localized sites, and, of course, you can relieve discomfort at a specific site. The topical is site-specific-much more so than local anesthetic. And the treatment is site-specific.
From an access-to-care standpoint, if people are handled in a way where you minimize pain, they’re willing to access care.

It’s really a winner of a product in an office. Because it’s a topical, I can have my hygienists apply it very safely without any risk to the patients. That helps to prepare the site so I can work. I may be able to go to another location or another patient while they’re putting the Oraqix in.

In summary
It helps to make care more efficient financially, and especially emotionally, for patients. I couldn’t be more positive about what it does. It’s less threatening biologically. If you’re injecting someone, you’re really putting something into the biological system. But using Oraqix really is a positive.

Hygienists weigh in: The most helpful hygiene products

Continue reading on Page 2 ...

More about Oraqix
Oraqix is a topically applied amide drug approved by the FDA for scaling and root planing procedures.

Important Risk Information
• Oraqix is not for injection.
• Oraqix is contraindicated in patients who are hypersensitive to local anesthetics.
• Oraqix should not be used in patients with congenital or idiopathic methemoglobinemia.
• Oraqix should be used during pregnancy only if the benefits outweigh the risks.
• Exercise caution when administering to a nursing woman.
• Most common adverse reactions ( >15 percent) are application site reactions, including pain, soreness, irritation, numbness, ulcerations, vesicles, edema, abscess and/or redness.

Oraqix
Oraqix, a combination of lidocaine and prilocaine, is uniquely combined with a thermosetting system to deliver pain relief where it’s needed. Combining both of these amides into a single treatment provides dual benefits that are important for creating an appropriate anesthetizing effect, fast onset and a duration that should be long enough to work for the entire treatment.

Category cruncher: Predictable posterior composites

Recent Videos
DS World 2024 Interview with Dentsply Sirona President and CEO Simon Campion in Las Vegas.
Greg Campbell, DDS, talks about the next generation zirconia blocks from Kuraray at DS World in Las Vegas.
At DS World 24, Max Milz, Dentsply Sirona VP, Connected Technology Solutions, talks about the company's new Primescan 2 intraoral scanning solution and how it fits in with a variety of digital dentistry workflows.
CDA 2024 Video Interview with Kuraray Noritake's Dinesh Weerasinghe and Richard Young, DDS
2024 Dental Products Report Spring Selection Bracket Reveal Video
2024 Chicago Dental Society Midwinter Meeting – Interview with Peter Maroon, business development and sales lead at Spectrum Solutions® on the new salivary diagnostic test, SimplyPERIO.
Product Bites – March 8, 2024 Part 2
Product Bites – March 8, 2024 Part 1
Contemporary Cosmetic Dentistry – Part II: Arresting Marginal Caries
© 2024 MJH Life Sciences

All rights reserved.